samedan logo
 
 
 
spacer
home > pmps > summer 2018 > pharma flourishing
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Pharma Flourishing

“Welcome to CPhI Worldwide 2018! The event returns in what has been a particularly successful year for pharmaceuticals. As an industry, we have seen a truly stellar year for new drugs – with an outstanding 46 FDA approvals in 2017 and many more to come. With the approval of Luxturna heralding a new age of fast-tracked gene therapies, growth in artificial intelligence, and advances in 3D printing, pharma is expecting a time of even greater collaboration and innovation. This year, with more on-site content than ever before, we look forward to welcoming our guests and providing a platform for building relationships that drive business growth,” says Orhan Caglayan, Brand Director Europe, at UBM (part of Informa).

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

Print this page
Send to a friend
Privacy statement
News and Press Releases

Lubrizol Life Science Health awarded grant for generic contraceptive injection research to advance women’s health worldwide

The Lubrizol Corporation has announced that the contract development and manufacturing organization (CDMO) of Lubrizol Life Science Health (LLS Health) has been awarded a grant to support its research on injectable contraceptive formulations designed to bring accessible contraceptive products to women in developing nations.
More info >>

White Papers

Delivering Fit For Purpose Biomanufacturing CHO Cell Lines

Fujifilm Diosynth Biotechnologies

The challenge during mammalian cell line development is to identify and isolate stable, high expressing cell lines producing product with the appropriate critical product quality attributes rapidly, reproducibly and with relative ease. Obtaining a host cell line that inherently exhibits desirable biomanufacturing attributes can therefore have a significantly positive effect on the identification of recombinant cell lines with desired traits during cell line development screens. In this study, we demonstrate that it is possible to exploit intrinsic heterogeneity within host cell populations and identify host cell lines which are more “fit for purpose”.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement